CYCS and stroke disorder: Methylene blue alters the flow of the electrons through the ETC by acting as an electron carrier between NADH and cytochrome c. Interestingly, methylene blue is an approved FDA drug for Alzheimer’s disease and Parkinson’s disorders [100], which may advance its use for stroke patients.